Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 8/2013

01.08.2013 | Editorial

Psychopharmacological treatment in children: always keeping an eye on adherence and ethics

verfasst von: Aribert Rothenberger, Lillian Geza Rothenberger

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Excerpt

Within the last few years, several psychopharmaca, formerly used off-label, received an on-label status for drug treatment in Child and Adolescent Psychiatry (CAP) (e.g., fluoxetine, fluvoxamine, risperidone), but beyond that new options were quite rare (e.g., aripiprazole and melatonin; [13]). …
Fußnoten
1
This is a Joint Venture of ECAP and ESCAP. The research Prize is sponsored by Shire Germany.
 
Literatur
1.
Zurück zum Zitat Doyen C, Mighiu D, Kaye K (2011) Melatonin in children with autistic spectrum disorders: recent and practical data. Eur Child Adolesc Psychiatry 20:231–239PubMedCrossRef Doyen C, Mighiu D, Kaye K (2011) Melatonin in children with autistic spectrum disorders: recent and practical data. Eur Child Adolesc Psychiatry 20:231–239PubMedCrossRef
2.
Zurück zum Zitat Yoo HK, Lee JS, Paik KW et al (2011) Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders. Eur Child Adolesc Psychiatry 20:127–135PubMedCrossRef Yoo HK, Lee JS, Paik KW et al (2011) Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders. Eur Child Adolesc Psychiatry 20:127–135PubMedCrossRef
3.
Zurück zum Zitat Kiriono E (2012) Efficacy and safety of aripiprazole in child and adolescent patients. Eur Child Adolesc Psychiatry 21:361–368CrossRef Kiriono E (2012) Efficacy and safety of aripiprazole in child and adolescent patients. Eur Child Adolesc Psychiatry 21:361–368CrossRef
4.
Zurück zum Zitat Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry 20:173–196PubMedCrossRef Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ, ESSTS Guidelines Group (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry 20:173–196PubMedCrossRef
5.
Zurück zum Zitat Rothenberger A, Döpfner M (2011) Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence. Eur Child Adolesc Psychiatry 20(Suppl 2):S235–S242PubMedCrossRef Rothenberger A, Döpfner M (2011) Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence. Eur Child Adolesc Psychiatry 20(Suppl 2):S235–S242PubMedCrossRef
6.
Zurück zum Zitat Graham J, Banaschewski T, Buitelaar J et al (2011) European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20:17–37PubMedCrossRef Graham J, Banaschewski T, Buitelaar J et al (2011) European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20:17–37PubMedCrossRef
7.
Zurück zum Zitat Martinez-Ortega JM, Funes-Godoy S, Diaz-Atienza F, Gutiérrez-Rojas L, Pérez-Costilla L, Gurpegui M (2013) Weight gain and increased body mass index among children and adolescents treated with antipsychotics: a critical review. Eur Child Adolesc Psychiatry (this issue) Martinez-Ortega JM, Funes-Godoy S, Diaz-Atienza F, Gutiérrez-Rojas L, Pérez-Costilla L, Gurpegui M (2013) Weight gain and increased body mass index among children and adolescents treated with antipsychotics: a critical review. Eur Child Adolesc Psychiatry (this issue)
8.
Zurück zum Zitat Rothenberger A, Becker A, Breuer D (2011) An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence. Eur Child Adolesc Psychiatry 20(Suppl 2):S257–S265PubMedCrossRef Rothenberger A, Becker A, Breuer D (2011) An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence. Eur Child Adolesc Psychiatry 20(Suppl 2):S257–S265PubMedCrossRef
9.
Zurück zum Zitat Dörks M, Langner I, Dittmann U, Timmer A, Garbe E (2013) Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study. Eur Child Adolesc Psychiatry (this issue) Dörks M, Langner I, Dittmann U, Timmer A, Garbe E (2013) Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study. Eur Child Adolesc Psychiatry (this issue)
10.
Zurück zum Zitat Murray ML, de Vries CS, Wong IC (2004) A drug utilization study on antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 89:1098–1102PubMedCrossRef Murray ML, de Vries CS, Wong IC (2004) A drug utilization study on antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 89:1098–1102PubMedCrossRef
11.
Zurück zum Zitat Mcnicholas F (2012) To adhere or not, and what we can do to help. Eur Child Adolesc Psychiatry 21:657–663PubMedCrossRef Mcnicholas F (2012) To adhere or not, and what we can do to help. Eur Child Adolesc Psychiatry 21:657–663PubMedCrossRef
12.
Zurück zum Zitat Roedelof AJM, Bongers IL, Van Nieuwenhuizen C (2013) Treatment engagement in adolescents with severe psychiatric problems: a latent class analysis. Eur Child Adolesc Psychiatry (this issue) Roedelof AJM, Bongers IL, Van Nieuwenhuizen C (2013) Treatment engagement in adolescents with severe psychiatric problems: a latent class analysis. Eur Child Adolesc Psychiatry (this issue)
13.
Zurück zum Zitat Kölch M, Ludolph AG, Plener PL, Fangerau H, Vitiello B, Fegert JM (2010) Safeguarding children’s rights in psychopharmacological research: ethical and legal issues. Curr Pharm Des 16:2398–2406PubMedCrossRef Kölch M, Ludolph AG, Plener PL, Fangerau H, Vitiello B, Fegert JM (2010) Safeguarding children’s rights in psychopharmacological research: ethical and legal issues. Curr Pharm Des 16:2398–2406PubMedCrossRef
14.
Zurück zum Zitat Spetie L, Arnold LE (2007) Ethical issues in child psychopharmacology research and practice: emphasis on preschoolers. Psychopharmacology 191:15–26PubMedCrossRef Spetie L, Arnold LE (2007) Ethical issues in child psychopharmacology research and practice: emphasis on preschoolers. Psychopharmacology 191:15–26PubMedCrossRef
15.
Zurück zum Zitat Haynes RB (2001) Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev, Issue 1 Haynes RB (2001) Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev, Issue 1
16.
Zurück zum Zitat Ferrin M, Ruiz-Veguilla, Blanc-Betes M, El Abd S, Lax-Pericall T, Sinclair M, Taylor E (2012) Evaluation of attitudes towards treatment in adolescents with attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 21:387–401PubMedCrossRef Ferrin M, Ruiz-Veguilla, Blanc-Betes M, El Abd S, Lax-Pericall T, Sinclair M, Taylor E (2012) Evaluation of attitudes towards treatment in adolescents with attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 21:387–401PubMedCrossRef
17.
Zurück zum Zitat Bloemsma JM, Boer F, Arnold R, Banaschewski T, Faraone SV, Buitelaar JK, Sergeant JA, Rommelse N, Oosterlaan J (2012) Comorbid anxiety and neurocognitive dysfunctions in children with ADHD. Eur Child Adolesc Psychiatry 22:225–234PubMedCrossRef Bloemsma JM, Boer F, Arnold R, Banaschewski T, Faraone SV, Buitelaar JK, Sergeant JA, Rommelse N, Oosterlaan J (2012) Comorbid anxiety and neurocognitive dysfunctions in children with ADHD. Eur Child Adolesc Psychiatry 22:225–234PubMedCrossRef
Metadaten
Titel
Psychopharmacological treatment in children: always keeping an eye on adherence and ethics
verfasst von
Aribert Rothenberger
Lillian Geza Rothenberger
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 8/2013
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-013-0445-3

Weitere Artikel der Ausgabe 8/2013

European Child & Adolescent Psychiatry 8/2013 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.